KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Operating Expenses (2016 - 2025)

Zimmer Biomet Holdings has reported Operating Expenses over the past 17 years, most recently at $2.1 billion for Q4 2025.

  • Quarterly results put Operating Expenses at $2.1 billion for Q4 2025, up 27.84% from a year ago — trailing twelve months through Dec 2025 was $7.1 billion (up 11.58% YoY), and the annual figure for FY2025 was $7.1 billion, up 11.58%.
  • Operating Expenses for Q4 2025 was $2.1 billion at Zimmer Biomet Holdings, up from $1.7 billion in the prior quarter.
  • Over the last five years, Operating Expenses for ZBH hit a ceiling of $2.1 billion in Q4 2025 and a floor of $1.3 billion in Q1 2021.
  • Median Operating Expenses over the past 5 years was $1.6 billion (2023), compared with a mean of $1.6 billion.
  • Peak annual rise in Operating Expenses hit 111.59% in 2021, while the deepest fall reached 40.05% in 2021.
  • Zimmer Biomet Holdings' Operating Expenses stood at $1.6 billion in 2021, then rose by 12.78% to $1.9 billion in 2022, then fell by 14.43% to $1.6 billion in 2023, then increased by 3.05% to $1.6 billion in 2024, then rose by 27.84% to $2.1 billion in 2025.
  • The last three reported values for Operating Expenses were $2.1 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.8 billion (Q2 2025) per Business Quant data.